Skip to main
PGNY

Progyny (PGNY) Stock Forecast & Price Target

Progyny (PGNY) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Progyny is a promising investment due to its strong financial performance, successful launch of new products, diverse client base and confident expansion plans. Additionally, the company's track record of winning contracts and investment in technology showcase their potential for continued growth and profitability. With a new price target of $33 and completed share repurchase program, Progyny's stock is expected to continue its positive trajectory.

Bears say

Progyny is a leading fertility management company with a strong competitive position, best-in-class retention, and a large potential addressable market. However, the recent decline in birth rates and the potential risks associated with entering the insurance market could hinder the company's growth potential. Additionally, while management emphasized a disciplined capital allocation framework, it is possible that the company may prioritize growth over profitability in the future.

Progyny (PGNY) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Progyny (PGNY) Forecast

Analysts have given Progyny (PGNY) a Buy based on their latest research and market trends.

According to 8 analysts, Progyny (PGNY) has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Progyny (PGNY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.